C16 Biosciences, a biotech firm specializing in sustainable palm oil substitutes, has raised USD 4.5 million, comprising of a USD 3.5 million grant from the Bill & Melinda Gates Foundation and a USD 1 million investment from Elemental Excelerator.
The funding will be used to expand its Palmless platform by harnessing non-agriculturally derived feedstocks to create food-grade oils and fats and hire additional R&D staff.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.